Rekah Pharmaceutical Industry Stock Revenue
REKA Stock | ILA 1,325 115.00 7.99% |
Rekah Pharmaceutical Industry fundamentals help investors to digest information that contributes to Rekah Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Rekah Stock. The fundamental analysis module provides a way to measure Rekah Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rekah Pharmaceutical stock.
Rekah |
Rekah Pharmaceutical Industry Company Revenue Analysis
Rekah Pharmaceutical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Rekah Pharmaceutical Revenue | 263.95 M |
Most of Rekah Pharmaceutical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rekah Pharmaceutical Industry is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Based on the latest financial disclosure, Rekah Pharmaceutical Industry reported 263.95 M of revenue. This is 96.54% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The revenue for all Israel stocks is 97.2% higher than that of the company.
Rekah Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rekah Pharmaceutical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rekah Pharmaceutical could also be used in its relative valuation, which is a method of valuing Rekah Pharmaceutical by comparing valuation metrics of similar companies.Rekah Pharmaceutical is currently under evaluation in revenue category among related companies.
Rekah Fundamentals
Return On Equity | 0.0222 | |||
Return On Asset | 0.0208 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 316.92 M | |||
Shares Outstanding | 11.41 M | |||
Shares Owned By Insiders | 37.27 % | |||
Shares Owned By Institutions | 42.66 % | |||
Price To Book | 1.11 X | |||
Price To Sales | 0.63 X | |||
Revenue | 263.95 M | |||
Gross Profit | 65.16 M | |||
EBITDA | 36.2 M | |||
Net Income | 6.62 M | |||
Cash And Equivalents | 31.61 M | |||
Cash Per Share | 2.77 X | |||
Total Debt | 101.23 M | |||
Debt To Equity | 1.01 % | |||
Current Ratio | 1.99 X | |||
Book Value Per Share | 14.39 X | |||
Cash Flow From Operations | 21.17 M | |||
Earnings Per Share | 0.32 X | |||
Number Of Employees | 399 | |||
Beta | 0.0605 | |||
Market Capitalization | 193.93 M | |||
Total Asset | 437.09 M | |||
Retained Earnings | 49 M | |||
Working Capital | 156 M | |||
Current Asset | 246 M | |||
Current Liabilities | 90 M | |||
Z Score | 0.6 | |||
Annual Yield | 0.05 % | |||
Net Asset | 437.09 M | |||
Last Dividend Paid | 0.87 |
About Rekah Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rekah Pharmaceutical Industry's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rekah Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rekah Pharmaceutical Industry based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Rekah Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Rekah Pharmaceutical's short interest history, or implied volatility extrapolated from Rekah Pharmaceutical options trading.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rekah Pharmaceutical Industry. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Rekah Stock analysis
When running Rekah Pharmaceutical's price analysis, check to measure Rekah Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rekah Pharmaceutical is operating at the current time. Most of Rekah Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Rekah Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rekah Pharmaceutical's price. Additionally, you may evaluate how the addition of Rekah Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |